Cannon Global Investment Management LLC acquired a new position in BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Free Report) during the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund acquired 5,000 shares of the biotechnology company’s stock, valued at approximately $433,000. BioMarin Pharmaceutical […]
BioMarin Pharmaceutical (NASDAQ:BMRN) Now Covered by StockNews com theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) EVP Jeffrey Robert Ajer sold 5,000 shares of the company’s stock in a transaction that occurred on Wednesday, August 16th. The shares were sold at an average price of $90.00, for a total value of $450,000.00. Following the completion of the sale, the executive vice president now […]
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN – Get Free Report) EVP Jeffrey Robert Ajer sold 5,000 shares of the firm’s stock in a transaction on Wednesday, August 16th. The shares were sold at an average price of $90.00, for a total value of $450,000.00. Following the sale, the executive vice president now directly owns 60,804 shares of […]
BioMarin Pharmaceutical (NASDAQ:BMRN – Get Rating) is set to issue its quarterly earnings data after the market closes on Wednesday, April 26th. Analysts expect the company to announce earnings of $0.43 per share for the quarter. BioMarin Pharmaceutical has set its FY 2023 guidance at $1.80-$2.05 EPS.Individual that wish to register for the company’s earnings […]